Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG42925

CCDC127 Knockout huh-7 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Liver

  • Disease:

    Hepatocellular carcinoma

The CCDC127 Knockout Huh-7 Polyclonal Cells provide a CRISPR/Cas9-edited polyclonal knockout population of Huh-7 hepatocellular carcinoma cells for studying ciliogenesis and Hedgehog signaling in a liver context. CCDC127 is a centrosomal protein that interacts with SDCCAG8 to assemble primary cilia and activate Hedgehog target genes such as GLI1. This loss-of-function model is suitable for immunofluorescence, western blotting, RT-qPCR, drug screening, and functional assays exploring ciliary roles in liver cancer biology and centrosome-related pathways. It enables dissection of centrosomal protein networks and Hedgehog-driven tumorigenic mechanisms.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Huh-7

    Sex of Donor

    Male

    Age

    57 years

    Gene Name

    CCDC127

    Gene Identifier

    NCBI Gene ID 133957

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The CCDC127 Knockout Huh-7 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the Huh-7 hepatocellular carcinoma cell line. This pool carries a heterogeneous array of CCDC127 gene disruptions, providing a robust loss-of-function model for functional studies without clonal selection artifacts. It is suitable for immediate use in phenotyping assays and pathway analysis in a liver cell context.

Huh-7 is an adherent epithelial cell line isolated from a liver tumor of a 57-year-old Japanese male, widely employed to study hepatocyte biology, hepatocellular carcinoma (HCC), and drug metabolism. These well-differentiated cells express hepatocyte markers and retain hepatic functions, making them an appropriate model for examining ciliary signaling in liver pathology and oncogenesis.

CCDC127 is a centrosomal protein that localizes to centriolar satellites and promotes primary cilium assembly by interacting with SDCCAG8, PCM1, and CEP290. It facilitates intraflagellar transport (IFT) protein recruitment, enabling cilium-dependent Hedgehog signaling. In this pathway, ligand binding to PTCH1 derepresses SMO, leading to GLI transcription factor activation and expression of targets like GLI1 and PTCH1. CCDC127 loss disrupts ciliogenesis and attenuates Hedgehog transduction, potentially affecting ??-catenin crosstalk.

Primary cilia are present on cholangiocytes and some hepatocytes, and Hedgehog signaling regulates hepatic processes including fibrosis and regeneration. In HCC, aberrant Hedgehog activation is common. CCDC127 knockout in Huh-7 cells thus models ciliary dysfunction in a hepatocellular context, enabling investigation of how ciliogenesis defects influence tumor cell proliferation, migration, and signaling. This system allows dissection of centrosome?Ccilium?CHedgehog interactions in liver cancer.

The polyclonal knockout cells are amenable to immunofluorescence detection of ciliary markers (acetylated ??-tubulin, ARL13B), ciliogenesis assays, Western blotting for CCDC127, SDCCAG8, and GLI1, and RT-qPCR analysis of Hedgehog targets (GLI1, PTCH1). They support co-immunoprecipitation, cell cycle flow cytometry, migration/invasion studies, drug screening for Hedgehog inhibitors, and RNA-seq. For more information, contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)